Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention

Background: Chemoprevention using selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women. Despite this evidence, few high-risk women who are eligible for chemoprevention utilize it as a risk-reducing strategy. Reas...

Full description

Bibliographic Details
Main Authors: Katherine D. Crew, Thomas B. Silverman, Alejandro Vanegas, Meghna S. Trivedi, Jill Dimond, Jennie Mata, Margaret Sin, Tarsha Jones, Mary Beth Terry, Wei-Yann Tsai, Rita Kukafka
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Contemporary Clinical Trials Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865419301954